Literature DB >> 2298875

Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.

J B Jackson1, S Y Kwok, J J Sninsky, J S Hopsicker, K J Sannerud, F S Rhame, K Henry, M Simpson, H H Balfour.   

Abstract

Between February 1987 and October 1988, peripheral mononuclear blood cells (PBMC) from 409 adult individuals antibody positive by Western (immuno-)blot for human immunodeficiency virus type 1 (HIV-1) (56 acquired immunodeficiency syndrome [AIDS] patients, 88 patients with AIDS-related complex, and 265 asymptomatic individuals) were consecutively cultured for HIV-1 or tested for the presence of HIV-1 DNA sequences by a polymerase chain reaction assay (PCR). We isolated HIV-1 or detected HIV-1 DNA sequences from the PBMC of all 409 HIV-1 antibody-positive individuals. None of 131 healthy HIV-1 antibody-negative individuals were HIV-1 culture positive, nor were HIV-1 DNA sequences detected by PCR in the blood specimens of 43 seronegative individuals. In addition, HIV-1 PCR and HIV-1 culture were compared in testing the PBMC of 59 HIV-1 antibody-positive and 20 HIV-1 antibody-negative hemophiliacs. Both methods were found to have sensitivities and specificities of at least 97 and 100%, respectively. In contrast, the sensitivities of serum HIV-1 antigen testing in AIDS patients and asymptomatic seropositive patients were 42 and 17%, respectively. Our ability to directly demonstrate HIV-1 infection in all HIV-1 antibody-positive individuals provides definitive support that HIV-1 antibody positivity is associated with present HIV-1 infection. Moreover, the sensitivities and specificities of PCR and culture for the detection of HIV-1 appear to be equivalent, and both methods are superior to testing for HIV-1 antigen in serum for the direct detection of HIV-1.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2298875      PMCID: PMC269529          DOI: 10.1128/jcm.28.1.16-19.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Comparative studies on use of fresh and frozen peripheral blood lymphocyte specimens for isolation of human immunodeficiency virus and effects of cell lysis on isolation efficiency.

Authors:  D Gallo; J S Kimpton; P J Dailey
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

2.  DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells.

Authors:  C Y Ou; S Kwok; S W Mitchell; D H Mack; J J Sninsky; J W Krebs; P Feorino; D Warfield; G Schochetman
Journal:  Science       Date:  1988-01-15       Impact factor: 47.728

3.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

4.  Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.

Authors:  J Goudsmit; J M Lange; D A Paul; G J Dawson
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

5.  HIV is not the cause of AIDS.

Authors:  P Duesberg
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

Review 6.  Retroviruses as carcinogens and pathogens: expectations and reality.

Authors:  P H Duesberg
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701

7.  Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. Potential clinical importance.

Authors:  J P Allain; Y Laurian; D A Paul; F Verroust; M Leuther; C Gazengel; D Senn; M J Larrieu; C Bosser
Journal:  N Engl J Med       Date:  1987-10-29       Impact factor: 91.245

8.  Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection.

Authors:  J Albert; H Gaines; A Sönnerborg; G Nyström; P O Pehrson; F Chiodi; M von Sydow; L Moberg; K Lidman; B Christensson
Journal:  J Med Virol       Date:  1987-09       Impact factor: 2.327

9.  Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients.

Authors:  D A Paul; L A Falk; H A Kessler; R M Chase; B Blaauw; D S Chudwin; A L Landay
Journal:  J Med Virol       Date:  1987-08       Impact factor: 2.327

10.  Isolation frequency and growth properties of HIV-variants: multiple simultaneous variants in a patient demonstrated by molecular cloning.

Authors:  H von Briesen; W B Becker; K Henco; E B Helm; H R Gelderblom; H D Brede; H Rübsamen-Waigmann
Journal:  J Med Virol       Date:  1987-09       Impact factor: 2.327

View more
  34 in total

1.  In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.

Authors:  Fatih M Uckun; Sanjive Qazi; Sharon Pendergrass; Elizabeth Lisowski; Barbara Waurzyniak; Chun-Lin Chen; T K Venkatachalam
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

2.  Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40.

Authors:  J Verhoef; G Gekker; A Erice; P K Peterson; H H Balfour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

Review 3.  Molecular techniques in the diagnosis of human infectious diseases.

Authors:  U Desselberger; K Collingham
Journal:  Genitourin Med       Date:  1990-10

4.  Detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction amplification and capture hybridization in microtiter wells.

Authors:  G H Keller; D P Huang; M M Manak
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

5.  Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.

Authors:  H Liu; X Wu; H Xiao; J A Conway; J C Kappes
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Comparison of three nonradioisotopic polymerase chain reaction-based methods for detection of human immunodeficiency virus type 1.

Authors:  A J Whetsell; J B Drew; G Milman; R Hoff; E A Dragon; K Adler; J Hui; P Otto; P Gupta; H Farzadegan
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

7.  Evaluation of an infectivity standard for real-time quality control of human immunodeficiency virus type 1 quantitative micrococulture assays. Participating Laboratories of The AIDS Clinical Trials Group.

Authors:  W A Scott; D Brambilla; E Siwak; C Beatty; J Bremer; R W Coombs; H Farzadegan; S A Fiscus; S M Hammer; F B Hollinger; N Khan; S Rasheed; P S Reichelderfer
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

Review 8.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

9.  Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.

Authors:  X Wu; H Liu; H Xiao; J A Conway; E Hunter; J C Kappes
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

10.  Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral protein.

Authors:  A Erice; H H Balfour; D E Myers; V L Leske; K J Sannerud; V Kuebelbeck; J D Irvin; F M Uckun
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.